These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 24326201)
1. Hypomethylation of SNCA in blood of patients with sporadic Parkinson's disease. Ai SX; Xu Q; Hu YC; Song CY; Guo JF; Shen L; Wang CR; Yu RL; Yan XX; Tang BS J Neurol Sci; 2014 Feb; 337(1-2):123-8. PubMed ID: 24326201 [TBL] [Abstract][Full Text] [Related]
2. Parkinson's disease correlates with promoter methylation in the α-synuclein gene. Pihlstrøm L; Berge V; Rengmark A; Toft M Mov Disord; 2015 Apr; 30(4):577-80. PubMed ID: 25545759 [TBL] [Abstract][Full Text] [Related]
4. Hypomethylation of intron1 of α-synuclein gene does not correlate with Parkinson's disease. Guhathakurta S; Evangelista BA; Ghosh S; Basu S; Kim YS Mol Brain; 2017 Feb; 10(1):6. PubMed ID: 28173842 [TBL] [Abstract][Full Text] [Related]
5. DNA methylation levels of α-synuclein intron 1 in the aging brain. de Boni L; Riedel L; Schmitt I; Kraus TFJ; Kaut O; Piston D; Akbarian S; Wüllner U Neurobiol Aging; 2015 Dec; 36(12):3334.e7-3334.e11. PubMed ID: 26422361 [TBL] [Abstract][Full Text] [Related]
6. The rs3756063 polymorphism is associated with SNCA methylation in the Chinese Han population. Wei Y; Yang N; Xu Q; Sun Q; Guo J; Li K; Liu Z; Yan X; Zhu X; Tang B J Neurol Sci; 2016 Aug; 367():11-4. PubMed ID: 27423554 [TBL] [Abstract][Full Text] [Related]
7. alpha-Synuclein and Parkinson disease susceptibility. Winkler S; Hagenah J; Lincoln S; Heckman M; Haugarvoll K; Lohmann-Hedrich K; Kostic V; Farrer M; Klein C Neurology; 2007 Oct; 69(18):1745-50. PubMed ID: 17872362 [TBL] [Abstract][Full Text] [Related]
8. Expansion of the Parkinson disease-associated SNCA-Rep1 allele upregulates human alpha-synuclein in transgenic mouse brain. Cronin KD; Ge D; Manninger P; Linnertz C; Rossoshek A; Orrison BM; Bernard DJ; El-Agnaf OM; Schlossmacher MG; Nussbaum RL; Chiba-Falek O Hum Mol Genet; 2009 Sep; 18(17):3274-85. PubMed ID: 19498036 [TBL] [Abstract][Full Text] [Related]
9. Genetic variability in the SNCA gene influences alpha-synuclein levels in the blood and brain. Fuchs J; Tichopad A; Golub Y; Munz M; Schweitzer KJ; Wolf B; Berg D; Mueller JC; Gasser T FASEB J; 2008 May; 22(5):1327-34. PubMed ID: 18162487 [TBL] [Abstract][Full Text] [Related]
11. Alpha-synuclein polymorphisms are associated with Parkinson's disease in a Saskatchewan population. Rajput A; Vilariño-Güell C; Rajput ML; Ross OA; Soto-Ortolaza AI; Lincoln SJ; Cobb SA; Heckman MG; Farrer MJ; Rajput A Mov Disord; 2009 Dec; 24(16):2411-4. PubMed ID: 19890971 [TBL] [Abstract][Full Text] [Related]
12. Multiple alpha-synuclein gene polymorphisms are associated with Parkinson's disease in a Norwegian population. Myhre R; Toft M; Kachergus J; Hulihan MM; Aasly JO; Klungland H; Farrer MJ Acta Neurol Scand; 2008 Nov; 118(5):320-7. PubMed ID: 18485051 [TBL] [Abstract][Full Text] [Related]
13. Association of alpha-synuclein Rep1 polymorphism and Parkinson's disease: influence of Rep1 on age at onset. Hadjigeorgiou GM; Xiromerisiou G; Gourbali V; Aggelakis K; Scarmeas N; Papadimitriou A; Singleton A Mov Disord; 2006 Apr; 21(4):534-9. PubMed ID: 16250025 [TBL] [Abstract][Full Text] [Related]
14. Cerebellar alpha-synuclein levels are decreased in Parkinson's disease and do not correlate with SNCA polymorphisms associated with disease in a Swedish material. Westerlund M; Belin AC; Anvret A; Håkansson A; Nissbrandt H; Lind C; Sydow O; Olson L; Galter D FASEB J; 2008 Oct; 22(10):3509-14. PubMed ID: 18606870 [TBL] [Abstract][Full Text] [Related]
15. L-dopa increases α-synuclein DNA methylation in Parkinson's disease patients in vivo and in vitro. Schmitt I; Kaut O; Khazneh H; deBoni L; Ahmad A; Berg D; Klein C; Fröhlich H; Wüllner U Mov Disord; 2015 Nov; 30(13):1794-801. PubMed ID: 26173746 [TBL] [Abstract][Full Text] [Related]
16. Familial genes in sporadic disease: common variants of alpha-synuclein gene associate with Parkinson's disease. Ross OA; Gosal D; Stone JT; Lincoln SJ; Heckman MG; Irvine GB; Johnston JA; Gibson JM; Farrer MJ; Lynch T Mech Ageing Dev; 2007; 128(5-6):378-82. PubMed ID: 17531291 [TBL] [Abstract][Full Text] [Related]
17. Australian data and meta-analysis lend support for alpha-synuclein (NACP-Rep1) as a risk factor for Parkinson's disease. Mellick GD; Maraganore DM; Silburn PA Neurosci Lett; 2005 Feb; 375(2):112-6. PubMed ID: 15670652 [TBL] [Abstract][Full Text] [Related]
18. Methylation regulates alpha-synuclein expression and is decreased in Parkinson's disease patients' brains. Jowaed A; Schmitt I; Kaut O; Wüllner U J Neurosci; 2010 May; 30(18):6355-9. PubMed ID: 20445061 [TBL] [Abstract][Full Text] [Related]
19. Downregulation of SNCA Expression by Targeted Editing of DNA Methylation: A Potential Strategy for Precision Therapy in PD. Kantor B; Tagliafierro L; Gu J; Zamora ME; Ilich E; Grenier C; Huang ZY; Murphy S; Chiba-Falek O Mol Ther; 2018 Nov; 26(11):2638-2649. PubMed ID: 30266652 [TBL] [Abstract][Full Text] [Related]
20. Methylation of α-synuclein and leucine-rich repeat kinase 2 in leukocyte DNA of Parkinson's disease patients. Tan YY; Wu L; Zhao ZB; Wang Y; Xiao Q; Liu J; Wang G; Ma JF; Chen SD Parkinsonism Relat Disord; 2014 Mar; 20(3):308-13. PubMed ID: 24398085 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]